VANCOUVER, BC / ACCESS Newswire / June 27, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, ...

VANCOUVER, BC / ACCESS Newswire / June 27, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, I ...

Onco-Innovations views this Expression of Interest as a strong validation of the PROmAI initiative's relevance and potential impact in the rapidly evolving field of oncology R&D.

Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025 Provided by ACCESS Newswire Jun 25, 2025, 10:00:00 PM.

Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to pursue the prevention and treatment of cancer through ...

Conference ID: ONCO. The Company will issue a press release after the conclusion of the conference call. About Onco-Innovations Limited. Onco-Innovations is a Canadian-based company dedicated to ...

Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025 ...

Onco-rheumatology is emerging as a vital transdisciplinary field, addressing the rising overlap of autoimmune diseases and ...

or. Participant Toll-Free Number: 888-304-1803 International / Direct Dial: 848-488-9277 Germany: +49 69 5899 64215. Conference ID: ONCO. The Company will issue a press release after the ...

Detailed price information for Onco-Innovations Limited (ONCO-CN) from The Globe and Mail including charting and trades.

A high-level overview of Onco-Innovations Limited (ONCO:CA) stock. View (ONCO:CA) real-time stock price, chart, news, analysis, analyst reviews and more.